Inhibition of mitochondrial creatine kinase activity from rat cerebral cortex by methylmalonic acid

P F Schuck1, R B Rosa, L F Pettenuzzo

  • 1Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2600 Anexo, CEP 90035-003, Porto Alegre, RS, Brazil.

Insights

Methylmalonic acid (MMA) accumulation in methylmalonic acidemia (MMAemia) inhibits brain creatine kinase (CK) activity, potentially contributing to neurodegeneration. Other acids did not show this effect.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Metabolic Disorders

Background:

  • Methylmalonic acidemia (MMAemia) is a neurometabolic disorder marked by methylmalonic acid (MMA) accumulation.
  • Neurological damage is a primary characteristic of MMAemia, but the exact mechanisms remain unclear.
  • Creatine kinase (CK) plays a crucial role in maintaining brain energy homeostasis.

Purpose of the Study:

  • To investigate the impact of MMA, propionic acid (PA), and tiglic acid (TA) on creatine kinase (CK) activity in the rat cerebral cortex.
  • To explore the potential role of MMA-induced CK inhibition in the neurodegeneration observed in MMAemia.

Main Methods:

  • Measurement of total (tCK), cytosolic (Cy-CK), and mitochondrial (Mi-CK) creatine kinase activities in Wistar rat cerebral cortex homogenates.
  • Incubation of enzyme preparations with varying concentrations of MMA, PA, and TA.
  • Assessment of MMA's inhibitory mechanism using reduced glutathione pre-incubation.

Main Results:

  • Methylmalonic acid (MMA) significantly inhibited total (tCK) and mitochondrial (Mi-CK) creatine kinase activities at 1 mM.
  • Cytosolic (Cy-CK) activity remained unaffected by MMA, while propionic acid (PA) and tiglic acid (TA) showed no inhibitory effects even at 5 mM.
  • MMA-induced inhibition was reversed by reduced glutathione, suggesting oxidation of thiol groups on the enzyme.

Conclusions:

  • Inhibition of creatine kinase (CK) by elevated methylmalonic acid (MMA) levels may be a key factor in the neurodegeneration associated with methylmalonic acidemia (MMAemia).
  • These findings suggest a potential mechanism for impaired brain energy metabolism and reduced phosphocreatine levels observed in MMAemia patients.